will no longer cover anti-obesity drugs like Ozempic and Wegovy when they're prescribed solely for weight loss. The drugs' high costs have caused an increase in premiums that "affect all members ...

Beyond losing weight, she gained confidence, health, and a renewed perspective on life. Her story continues to inspire thousands, proving that small, consistent steps can lead to extraordinary ...

The FDA has announced that popular weight loss medication tirzepatide is no longer in shortage, potentially removing cheaper versions of the drug from the market by early 2025. Tirzepatide is the ...

Starting in the new year, Independence Blue Cross, the region’s largest health insurer, will no longer cover anti-obesity drugs like Ozempic and Wegovy when they’re prescribed solely for weight loss.

Update: We've pulled the original content, which recommended Wubuntu, from this article. Your trust in ZDNET's recommendations is very important to us, and part of protecting that trust is letting ...

San Francisco's new self-described "anti-weight-based discrimination" expert is catching some attention online for a 2022 video where she insisted "no one has to be healthy," while speaking out ...

The San Francisco Department of Public Health’s latest consultant once made comments that “no one has to be healthy.” ...

And yes, they likely drank water. According to Niels H. Andersen, no definitive traces of beer brewing have been found in Denmark before the Bronze Age. However, as the two researchers from ...

“No bills should be passed Congress until January, 20, when @RealDonaldTrump takes office. None. Zero,” Musk said in a 2:13 p.m. post viewed by 42.6 million. More:Elon Musk, Vivek Ramaswamy ...

There’s no clear guidance for going off them, but there are clear risks. Suddenly stopping the drugs can lead patients to regain weight and worsen risk factors for diabetes and heart issues ...